<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110692</url>
  </required_header>
  <id_info>
    <org_study_id>826810</org_study_id>
    <nct_id>NCT03110692</nct_id>
  </id_info>
  <brief_title>Default Options to Reduce Unnecessary Daily Imaging During Palliative Radiation</brief_title>
  <official_title>Health System Initiative to Reduce Unnecessary Daily X-Ray Image Guidance During Palliative Radiation Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to reduce preference sensitive, unnecessary daily imaging during
      radiation treatment in which a pre-planned quality improvement default option for radiation
      treatment prescriptions will be introduced throughout the network of Penn Radiation Oncology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this study is to reduce preference sensitive, unnecessary daily imaging during
      radiation treatment in which a pre-planned quality improvement default option for radiation
      treatment prescriptions will be introduced throughout the network of Penn Radiation Oncology.
      This study is a prospectively designed, observational trial with two comparison groups: (1) a
      usual practice group (control group) and (2) a default radiation treatment prescription group
      (intervention group), in which the usual practice group will subsequently rollover from
      control to intervention so that all sites and physicians in the practice network of Penn
      Radiation Oncology are exposed to intervention. The purpose of this study is to reduce
      preference sensitive, unnecessary daily imaging during radiation treatment with the
      implementation of a quality improvement initiative within 5 sites of Penn Radiation Oncology.
      We aim to leverage the introduction of a default prescription option to reduce the use of
      daily imaging in palliative intent cases where it has limited clinical benefit and adds to
      cost burden. Our objective is to encourage more patient-centric clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 10, 2017</start_date>
  <completion_date type="Actual">November 9, 2017</completion_date>
  <primary_completion_date type="Actual">November 9, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of patients receiving daily imaging</measure>
    <time_frame>4 months post initiation of default</time_frame>
    <description>Radiology tests including x-rays and CT scans</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1084</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Usual practice (control)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The usual practice group will rollover to the intervention arm after 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Default initiation: Introduce a default prescription template in the palliative setting in order to reduce unnecessary daily image guided radiation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Default initiation</intervention_name>
    <description>A default prescription template will be introduced in the palliative setting in order to reduce unnecessary daily image guided radiation.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Radiation treatment courses with palliative intent

          -  Palliative treatment of bone, soft tissue, and intracranial metastases

          -  Photon radiation with 3D conformal therapy (3DCRT) only

        Exclusion Criteria:

          -  Use of intensity modulated radiation (IMRT) or stereotactic body radiation (SBRT) as
             radiation treatment modality

          -  Retreatment to same site

          -  Proton radiation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin Bekelman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mitesh Patel, MD, MBA, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Patel MS, Volpp KG. Leveraging insights from behavioral economics to increase the value of health-care service provision. J Gen Intern Med. 2012 Nov;27(11):1544-7. doi: 10.1007/s11606-012-2050-4. Epub 2012 Apr 5. Review.</citation>
    <PMID>22549296</PMID>
  </reference>
  <reference>
    <citation>Patel MS, Reed DA, Loertscher L, McDonald FS, Arora VM. Teaching residents to provide cost-conscious care: a national survey of residency program directors. JAMA Intern Med. 2014 Mar;174(3):470-2. doi: 10.1001/jamainternmed.2013.13222. Erratum in: JAMA Intern Med. 2014 Mar;174(3):484.</citation>
    <PMID>24343037</PMID>
  </reference>
  <reference>
    <citation>Sinaiko AD, Rosenthal MB. Examining A Health Care Price Transparency Tool: Who Uses It, And How They Shop For Care. Health Aff (Millwood). 2016 Apr;35(4):662-70. doi: 10.1377/hlthaff.2015.0746.</citation>
    <PMID>27044967</PMID>
  </reference>
  <reference>
    <citation>White C, Ginsburg PB, Tu HT, Reschovsky JD, Smith JM LK. Healthcare price transparency: policy approaches and estimated impacts on spending. Westhealth Policy Cent. 2014:1-24. http://www.westhealth.org/wp-content/uploads/2015/.</citation>
  </reference>
  <reference>
    <citation>Konski A. The war on cancer: progress at what price? J Clin Oncol. 2011 Apr 20;29(12):1503-4. doi: 10.1200/JCO.2010.34.2758. Epub 2011 Mar 14.</citation>
    <PMID>21402613</PMID>
  </reference>
  <reference>
    <citation>Nguyen PL, Gu X, Lipsitz SR, Choueiri TK, Choi WW, Lei Y, Hoffman KE, Hu JC. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol. 2011 Apr 20;29(12):1517-24. doi: 10.1200/JCO.2010.31.1217. Epub 2011 Mar 14.</citation>
    <PMID>21402604</PMID>
  </reference>
  <reference>
    <citation>Nguyen TK, Goodman CD, Boldt RG, Warner A, Palma DA, Rodrigues GB, Lock MI, Mishra MV, Zaric GS, Louie AV. Evaluation of Health Economics in Radiation Oncology: A Systematic Review. Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1006-14. doi: 10.1016/j.ijrobp.2015.12.359. Epub 2015 Dec 24. Review.</citation>
    <PMID>26883562</PMID>
  </reference>
  <reference>
    <citation>Ojerholm E, Anderson N, Patel K, Wang P, Lustig RA, Alonso-Basanta M, Kurtz G, Jones JA. Impact of image guidance during whole-brain radiation therapy. Pract Radiat Oncol. 2016 Nov - Dec;6(6):e345-e351. doi: 10.1016/j.prro.2016.03.006. Epub 2016 Mar 19.</citation>
    <PMID>27156423</PMID>
  </reference>
  <reference>
    <citation>Arabloo J, Hamouzadeh P, Mousavinezhad SM, Mobinizadeh M, Olyaeemanesh A, Pooyandjoo M. Health technology assessment of image-guided radiotherapy (IGRT): A systematic review of current evidence. Med J Islam Repub Iran. 2016 Jan 18;30:318. eCollection 2016.</citation>
    <PMID>27390688</PMID>
  </reference>
  <reference>
    <citation>Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. A survey of image-guided radiation therapy use in the United States. Cancer. 2010 Aug 15;116(16):3953-60. doi: 10.1002/cncr.25129.</citation>
    <PMID>20564090</PMID>
  </reference>
  <reference>
    <citation>Nabavizadeh N, Elliott DA, Chen Y, Kusano AS, Mitin T, Thomas CR Jr, Holland JM. Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members. Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):850-7. doi: 10.1016/j.ijrobp.2015.09.035.</citation>
    <PMID>26972658</PMID>
  </reference>
  <reference>
    <citation>Clinical Guidelines: Radiation Therapy - CareCore National, LLC D/b/a eviCore Healthcare (eviCore).; 2016.</citation>
  </reference>
  <reference>
    <citation>Patel MS, Day S, Small DS, Howell JT 3rd, Lautenbach GL, Nierman EH, Volpp KG. Using default options within the electronic health record to increase the prescribing of generic-equivalent medications: a quasi-experimental study. Ann Intern Med. 2014 Nov 18;161(10 Suppl):S44-52. doi: 10.7326/M13-3001.</citation>
    <PMID>25402402</PMID>
  </reference>
  <reference>
    <citation>Patel MS, Day SC, Halpern SD, Hanson CW, Martinez JR, Honeywell S Jr, Volpp KG. Generic Medication Prescription Rates After Health System-Wide Redesign of Default Options Within the Electronic Health Record. JAMA Intern Med. 2016 Jun 1;176(6):847-8. doi: 10.1001/jamainternmed.2016.1691.</citation>
    <PMID>27159011</PMID>
  </reference>
  <reference>
    <citation>Ojerholm E, Halpern SD, Bekelman JE. Default Options: Opportunities to Improve Quality and Value in Oncology. J Clin Oncol. 2016 Jun 1;34(16):1844-7. doi: 10.1200/JCO.2015.64.8741. Epub 2016 Feb 16.</citation>
    <PMID>26884581</PMID>
  </reference>
  <reference>
    <citation>Maynard RA, Dong N. PowerUp!: A Tool for Calculating Minimum Detectable Effect Sizes and Minimum Required Sample Sizes for Experimental and Quasi- Experimental Design Studies. J Res Educ Eff. 2013;6(1):24-67. http://dx.doi.org/10.1080/19345747.2012.673143.</citation>
  </reference>
  <reference>
    <citation>Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, Goodacre S, Herrin J, Kerse N, McKinlay RJ, Wright A, Soumerai SB. A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation. J Clin Epidemiol. 2015 Mar;68(3):324-33. doi: 10.1016/j.jclinepi.2014.10.003. Epub 2014 Dec 11.</citation>
    <PMID>25499983</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

